insights_auto
Nega EDIT tushdi 3,61%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
arrow_downward
-3,61%(-0,090) 1K
2,44 US$
arrow_upward
+1,53% (+0,037)bedtimeYopilgandan keyin
Savdolar yopilgan: 23-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,44 US$
Yuqori
2,45 US$
Past
2,30 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,92 mln
Hajmi
1,31 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,44 US$
Yuqori
2,45 US$
Past
2,30 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,92 mln
Hajmi
1,31 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
Before You Buy the Vanguard S&P 500 ETF, There's 1 Sneaky Risk Investors Should Know
Foreign Policy Journal
·
1 soat oldin
S&P 500 (SPY) And Dow Jones Industrial Average (DJIA) Slide As Oil Prices Surge And AI Profitability Fears Persist
Traders Union
·
57 daqiqa oldin
Average stock rose over 1% while S&P 500 fell, Ryan Detrick notes
WSJ
·
1 kun oldin
Stocks Pulled in Two Directions, Fall to End Volatile Week
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida